Double Win at Healthcare Awards for QuantuMDx

29 November 2011

METRC partner QuantuMDx Group Ltd scooped two awards at the Cels Business for Life Awards 2011, held in November in Newcastle upon Tyne.  The Awards, now in their fifth year, showcase and celebrate the achievements of the North East of England’s brightest life science and healthcare companies.

QuantuMDx’s decision to relocate from London to Newcastle to take advantage of the facilities and expertise at Newcastle University including genotyping and gene sequencing expert Prof. Sir John Burn was facilitated by the N8 Centre for Molecular Engineering, METRC. This move and collaboration paid dividends with the company winning both the Innovation and Technology Awards.

The company is developing a hand held DNA sequencing and microarray device that could potentially be used by the police in roadside drug testing, by vets to detect infectious diseases and even by the military to provide early detection of biological warfare. The technology is still at an early stage but QuantuMDx has already secured a major grant from the NHS and is collaborating with some of the most respected global academic and industrial organisations who are interested in the product’s potential.

QuantuMDx Chief Executive Elaine Warburton collected the award and commented:

“The QuantuMDx team and I are thrilled to be awarded both the Business in Life Innovation and Technology awards in recognition of our groundbreaking handheld diagnostic and DNA sequencing technologies. After so many major challenges over the last few years since we set up the company, there is now so much to be proud of.”

“These awards are a real validation that we are truly on the road to success that will introduce ‘Star Trek-esque’ technologies capable of addressing not only the major health challenges across the world such as HIV, TB and malaria but also provide cheap, rapid and accurate tests that will let your doctor diagnose you within minutes and prescribe you the right drug, first time. Eventually you'll see this technology on your supermarket or pharmacist's shelf for you to diagnose yourself at home with a phone app for support!”

Additionally, Regener8 member Reinnervate, a company spun out of Durham University that develops novel artificial skin constructs for routine use in research, screening and compound testing programmes was a runner up in the Technology and HealthConnect categories on the night.

The N8 Research Partnership is working together to support industry and give them access to the world class research base in the North, creating 60 jobs and working with 200 businesses in the past three years.

Find out more about accessing world leading research through the N8 Research Partnership

Back to News